Helicobacter pylori vaccines and mechanisms of effective immunity: Is mucus the key?

Immunology and Cell Biology

Volumn 79, Issue 1, 2001, Pages 67-73

  Sutton, P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Effector mechanism; Helicobacter pylori; Immunisation; Mucus

Indexed keywords

HELICOBACTER PYLORI VACCINE; STOMACH MUCIN;

BACTERIAL COLONIZATION; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MOUSE; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; REVIEW; T LYMPHOCYTE;

ANIMALS; BACTERIAL ADHESION; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MUCINS; NIPPOSTRONGYLUS; RATS; STRONGYLIDA INFECTIONS; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NIPPOSTRONGYLUS BRASILIENSIS; RODENTIA;

EID: 0035133538     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2001.00977.x     Document Type: Review

References (68)

1. Unidentified curved bacillus on gastric epithelium in active chronic gastritis
2. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
3. Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole
4. Helicobacter pylori and gastric atrophy - Cancer paradoxes
5. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
6. Antibiotic resistance in Helicobacter pylori infection
7. A small animal model of human Helicobacter pylori active chronic gastritis
8. Development of a mouse model of Helicobacter pylori infection that mimics human disease
9. A standardized mouse model of Helicobacter pylori infection - Introducing the Sydney strain
10. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria
11. Further development of the Helicobacter pylori mouse vaccination model
12. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-liable enterotoxin (LT) as adjuvant
13. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoP(c) expressing urease A and B subunits
14. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B
15. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers
16. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers
17. Urease-based mucosal immunization against Helicobacter heilmannii infection induces corpus atrophy in mice
18. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice
19. Helicobacter-specific cell-mediated immune responses display a predominant TH1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice
20. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype
21. Oral immunization against Helicobacter pylori
22. Immunisation against Helicobacter infection in a mouse/Helicobacter felis model
23. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization
24. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis
25. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice
26. Local immune response to gastric Campylobacter in non-ulcer disease
27. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection
28. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses
29. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice
30. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies
31. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions
32. Murine CD4 T-cell response to Helicobacter infection - TH1 cells enhance gastritis and TH2 cells reduce bacterial load
33. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection
34. Failure of immunisation against Helicobacter infection in IL-4 mice: Evidence for the TH2 immune response as the basis for protective immunity
35. A mixed Th1/Th2 response may be necessary for effective immunity against Helicobacter
36. Th1 and Th2 cells contribute to protection but are also involved in the development of gastritis
37. Replication-defective adenovirus infection reduces Helicobacter felis colonization in the mouse in a gamma interferon- and interleukin-12-dependent manner
38. Histochemical study of Helicobacter pylori and surface mucous gel layer in various gastric lesions
39. Campylobacter pyloridis and gastritis: Association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium
40. Helicobacter pylori and the surface mucous gel layer of the human stomach
41. In vivo distribution of Helicobacter felis in the gastric mucus of the mouse: Experimental method and results
42. Changes in the structure of the mucous gel on the mucosal surface of the stomach in association with peptic ulcer disease
43. Mucin exocytosis: A major target for Helicobacter pylori
44. Effects of cytokines, without and with Helicobacter pylori components, on mucus secretion by cultured gastric epithelial cells
45. Evidence for proteolytic disruption of gastric mucus coat by Campylobacter pylori
46. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori proteases and lipases
47. Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel
48. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication
49. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides
50. Sulfatides inhibit binding of Helicobacter pylori to the gastric cancer Kato III cell line
51. In vitro binding of Helicobacter pylori to human gastric mucin
52. Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin
53. Helicobacter pylori interactions with human gastric mucin studied with a resonant mirror biosensor
54. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa
55. Adhesion of Pseudomonas aeruginosa to respiratory mucins and expression of mucin-binding proteins are increased by limiting iron during growth
56. The complete genome sequence of the gastric pathogen Helicobacter pylori
57. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
58. Co-operation between antibodies and cells in immunity to a nematode parasite
59. Immune-mediated alteration of the terminal sugars of goblet cell mucins in the small intestine of Nippostrongylus brasiliensis-infected rats
60. Protection against Nippostrongylus brasiliensis by adoptive immunization with immune thoracic duct lymphocytes
61. The protective capacities of fractionated immune thoracic duct lymphocytes against Nippostrongylus brasiliensis
62. Mucin-secreting cells in rats infected with Nippostrongylus brasiliensis
63. Nippostrongylus brasiliensis: Histochemical changes in the composition of mucins in goblet cells during infection in rats
64. Glycoconjugates in rat small intestinal mucosa during infection with the intestinal nematode Nippostrongylus brasiliensis
65. Reduced amount of intestinal mucus by treatment with anti-CD4 antibody interferes with the spontaneous cure of Nippostrongylus brasiliensis-infection in mice
66. Mast and goblet cell responses in the small intestine of rats concurrently infected with Nippostrongylus brasiliensis and Strongyloides ratti
67. Effect of gastric acid on Helicobacter pylori ecology